+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
From
From
From
Acute Pancreatitis Global Market Report 2024 - Product Thumbnail Image

Acute Pancreatitis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Aluminum Hydroxide - Global Strategic Business Report - Product Thumbnail Image

Aluminum Hydroxide - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
From
Octreotide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Octreotide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Loperamide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Loperamide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
MYTESI Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MYTESI Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Elafibranor Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Elafibranor Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • January 2024
  • 66 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more